Literature DB >> 10918499

Calcium phosphate precipitates augment adenovirus-mediated gene transfer to blood vessels in vitro and in vivo.

K Toyoda1, J J Andresen, J Zabner, F M Faraci, D D Heistad.   

Abstract

Adenovirus (Ad)-mediated gene transfer to blood vessels is relatively inefficient, probably because binding of adenovirus to the endothelium and adventitia seems to be limited. Association of calcium phosphate (CaPi) precipitates with adenovirus improves efficiency of gene transfer to some cells in culture and to mouse lung in vivo. In this study, we tested the hypothesis that CaPi is useful for adenovirus-mediated gene transfer to blood vessels. In fibroblast and endothelial cells in culture, Ad:CaPi coprecipitates greatly increased transgene expression. Ad:CaPi also enhanced transgene expression in both adventitia and endothelium of carotid arteries and aortae from rabbits studied ex vivo. After injection of Ad:CaPi into the cisterna magna of rabbits in vivo, the transgene product was markedly increased in leptomeninges of the ventral brain stem, including the adventitia of the basilar artery. We also examined mechanisms of enhanced gene transfer. Binding of adenovirus to fibroblast and endothelial cells in culture, and to the basilar artery in vivo, as determined using Southern blot analysis, was augmented by CaPi. Antibody to adenoviral fiber knob did not inhibit augmented transgene expression by Ad:CaPi. The finding suggests that improved adenoviral binding occurs primarily via a fiber-independent pathway. Thus, CaPi precipitates are useful for improvement of adenovirus-mediated gene transfer to blood vessels in vitro and in vivo.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10918499     DOI: 10.1038/sj.gt.3301214

Source DB:  PubMed          Journal:  Gene Ther        ISSN: 0969-7128            Impact factor:   5.250


  9 in total

Review 1.  The future of gene therapy for stroke.

Authors:  C A Gunnett; D D Heistad
Journal:  Curr Hypertens Rep       Date:  2001-02       Impact factor: 5.369

2.  ZIPK is critical for the motility and contractility of VSMCs through the regulation of nonmuscle myosin II isoforms.

Authors:  Satoshi Komatsu; Mitsuo Ikebe
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-03-14       Impact factor: 4.733

Review 3.  Gene transfer for cerebrovascular disease.

Authors:  V G Khurana; Z S Katusic
Journal:  Curr Cardiol Rep       Date:  2001-01       Impact factor: 2.931

Review 4.  Gene therapy for cerebral vascular disease: update 2003.

Authors:  Kazunori Toyoda; Yi Chu; Donald D Heistad
Journal:  Br J Pharmacol       Date:  2003-05       Impact factor: 8.739

5.  Vault nanoparticles containing an adenovirus-derived membrane lytic protein facilitate toxin and gene transfer.

Authors:  Cheng-Yu Lai; Chris M Wiethoff; Valerie A Kickhoefer; Leonard H Rome; Glen R Nemerow
Journal:  ACS Nano       Date:  2009-03-24       Impact factor: 15.881

6.  High Efficiency Ex Vivo Gene Transfer to Primary Murine B Cells Using Plasmid or Viral Vectors.

Authors:  Babak Moghimi; Irene Zolotukhin; Brandon K Sack; Roland W Herzog; Ou Cao
Journal:  J Genet Syndr Gene Ther       Date:  2011-03-15

7.  Calcium gluconate in phosphate buffered saline increases gene delivery with adenovirus type 5.

Authors:  Marko T Ahonen; Iulia Diaconu; Sari Pesonen; Anna Kanerva; Marc Baumann; Suvi T Parviainen; Brad Spiller; Vincenzo Cerullo; Akseli Hemminki
Journal:  PLoS One       Date:  2010-09-30       Impact factor: 3.240

8.  High performance DNA nano-carriers of carbonate apatite: multiple factors in regulation of particle synthesis and transfection efficiency.

Authors:  E H Chowdhury; Toshihiro Akaike
Journal:  Int J Nanomedicine       Date:  2007

9.  Optimization of an ex vivo gene transfer to the hamstrings tendons muscle remnants: potential for genetic enhancement of bone healing.

Authors:  Eduard Rod; Igor Matić; Maja Antunović; Vesna Vetma; Ivan Pavičić; Damir Hudetz; Inga Marijanović; Dragan Primorac; Alan Ivković
Journal:  Croat Med J       Date:  2019-06-13       Impact factor: 1.351

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.